Kyle A Blum
Overview
Explore the profile of Kyle A Blum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Blum K, Mehr J, Green T, Conroy L, Marino V, Kim D, et al.
Sex Med
. 2022 Jun;
10(4):100535.
PMID: 35667245
Background: Intracavernosal injection therapy (ICI) is an effective intervention used to treat erectile dysfunction (ED). It has been proposed that caution should be exercised when prescribing ICI to patients currently...
12.
Russo P, Blum K, Weng S, Graafland N, Bex A
Eur Urol Open Sci
. 2022 May;
40:125-132.
PMID: 35638088
Background: We managed a cohort of patients treated with minimally invasive surgery (MIS) for a kidney tumor presenting with atypical tumor recurrence (ATR) involving port sites, intraperitoneal carcinomatosis, and nephrectomy...
13.
Kansler E, Dadi S, Krishna C, Nixon B, Stamatiades E, Liu M, et al.
Nat Immunol
. 2022 May;
23(6):904-915.
PMID: 35618834
Malignancy can be suppressed by the immune system. However, the classes of immunosurveillance responses and their mode of tumor sensing remain incompletely understood. Here, we show that although clear cell...
14.
Mano R, Duzgol C, Ganat M, Goldman D, Blum K, Silagy A, et al.
Urol Oncol
. 2021 Sep;
39(11):791.e17-791.e24.
PMID: 34580025
Objective: Recurrent genomic alterations in clear cell renal cell carcinoma (ccRCC) have been associated with treatment outcomes; however, current preoperative predictive models do not include known genetic predictors. We aimed...
15.
Krishna C, DiNatale R, Kuo F, Srivastava R, Vuong L, Chowell D, et al.
Cancer Cell
. 2021 Apr;
39(5):662-677.e6.
PMID: 33861994
Clear cell renal cell carcinomas (ccRCCs) are highly immune infiltrated, but the effect of immune heterogeneity on clinical outcome in ccRCC has not been fully characterized. Here we perform paired...
16.
Blum K, Gupta S, Tickoo S, Chan T, Russo P, Motzer R, et al.
Nat Rev Urol
. 2020 Oct;
17(12):659-678.
PMID: 33051619
Sarcomatoid dedifferentiation is an uncommon feature that can occur in most histological subtypes of renal cell carcinomas (RCCs) and carries a decidedly poor prognosis. Historically, conventional treatments for sarcomatoid RCCs...
17.
Mano R, Duzgol C, Ganat M, Goldman D, Blum K, Silagy A, et al.
Urol Oncol
. 2020 Sep;
38(11):853.e1-853.e7.
PMID: 32900625
Objectives: Preoperative models, based on patient and tumor characteristics, predict risk for adverse outcomes after nephrectomy. Changes in renal tumor characteristics over the last decades, warrant further evaluation using contemporary...
18.
Hakimi A, Attalla K, DiNatale R, Ostrovnaya I, Flynn J, Blum K, et al.
Nat Commun
. 2020 Aug;
11(1):4168.
PMID: 32820162
There is conflicting data regarding the role of PBAF complex mutations and response to immune checkpoint blockade (ICB) therapy in clear cell renal cell carcinoma (ccRCC) and other solid tumors....
19.
Silagy A, Duzgol C, Marcon J, DiNatale R, Mano R, Blum K, et al.
Can Urol Assoc J
. 2020 Jun;
14(12):E625-E630.
PMID: 32569570
Introduction: New radiological tools can accurately provide preoperative three-dimensional spatial assessment of metastatic renal cell carcinoma (RCC). We aimed to determine whether the distribution, volume, shape, and fraction of RCC...
20.
Marcon J, DiNatale R, Sanchez A, Kotecha R, Gupta S, Kuo F, et al.
Clin Cancer Res
. 2020 Mar;
26(14):3629-3640.
PMID: 32220885
Purpose: Translocation renal cell carcinoma (tRCC) is a rare, aggressive renal cell carcinoma (RCC) subtype. There is currently limited understanding on the role of molecular alterations in the pathogenesis and...